An open label, pilot study involving the use of low dose oral minoxidil to treat permanent
Patients will be evaluated through clinical assessment, histology, quality of life
assessment, and adverse event monitoring. The data gathered from this study will be used to
determine the safety and efficacy of the treatment regimen for this subset of CIA patients.
The oral minoxidil regimen will be considered effective if significant clinical regrowth,
positive histological changes, and improved Quality of Life are reported after the onset of
If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.